Literature DB >> 16360598

Advances in stroke neuroprotection: hyperoxia and beyond.

Aneesh B Singhal1, Eng H Lo, Turgay Dalkara, Michael A Moskowitz.   

Abstract

Refinements in patient selection, improved methods of drug delivery, use of more clinically relevant animal stroke models, and the use of combination therapies that target the entire neurovascular unit make stroke neuroprotection an achievable goal. This article provides an overview of the major mechanisms of neuronal injury and the status of neuroprotective drug trials and reviews emerging strategies for treatment of acute ischemic stroke. Advances in the fields of stem cell transplantation, stroke recovery, molecular neuroimaging, genomics, and proteomics will provide new therapeutic avenues in the near future. These and other developments over the past decade raise expectations that successful stroke neuroprotection is imminent.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16360598     DOI: 10.1016/j.nic.2005.08.014

Source DB:  PubMed          Journal:  Neuroimaging Clin N Am        ISSN: 1052-5149            Impact factor:   2.264


  9 in total

Review 1.  Non-pharmaceutical therapies for stroke: mechanisms and clinical implications.

Authors:  Fan Chen; Zhifeng Qi; Yuming Luo; Taylor Hinchliffe; Guanghong Ding; Ying Xia; Xunming Ji
Journal:  Prog Neurobiol       Date:  2014-01-07       Impact factor: 11.685

Review 2.  Hyperbaric oxygen therapy in acute stroke: is it time for Justitia to open her eyes?

Authors:  Milija D Mijajlovic; Vuk Aleksic; Nenad Milosevic; Natan M Bornstein
Journal:  Neurol Sci       Date:  2020-01-11       Impact factor: 3.307

Review 3.  Ras family small GTPase-mediated neuroprotective signaling in stroke.

Authors:  Geng-Xian Shi; Douglas A Andres; Weikang Cai
Journal:  Cent Nerv Syst Agents Med Chem       Date:  2011-06-01

Review 4.  Pathophysiology of ischaemic stroke: insights from imaging, and implications for therapy and drug discovery.

Authors:  R R Moustafa; J-C Baron
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

5.  WebParc: a tool for analysis of the topography and volume of stroke from MRI.

Authors:  David N Kennedy; Christian Haselgrove; Nikos Makris; Donald M Goldin; Michael H Lev; David Caplan; Verne S Caviness
Journal:  Med Biol Eng Comput       Date:  2010-03       Impact factor: 2.602

6.  Normobaric hyperoxia-based neuroprotective therapies in ischemic stroke.

Authors:  Zhifeng Qi; Wenlan Liu; Yumin Luo; Xunming Ji; Ke Jian Liu
Journal:  Med Gas Res       Date:  2013-01-09

Review 7.  Gene therapy for stroke: 2006 overview.

Authors:  Yi Chu; Jordan D Miller; Donald D Heistad
Journal:  Curr Hypertens Rep       Date:  2007-03       Impact factor: 4.592

8.  Intrahemispheric Perfusion in Chronic Stroke-Induced Aphasia.

Authors:  Cynthia K Thompson; Matthew Walenski; YuFen Chen; David Caplan; Swathi Kiran; Brenda Rapp; Kristin Grunewald; Mia Nunez; Richard Zinbarg; Todd B Parrish
Journal:  Neural Plast       Date:  2017-03-05       Impact factor: 3.599

9.  Combination therapy with normobaric oxygen (NBO) plus thrombolysis in experimental ischemic stroke.

Authors:  Norio Fujiwara; Yoshihiro Murata; Ken Arai; Yasuhiro Egi; Jie Lu; Ona Wu; Aneesh B Singhal; Eng H Lo
Journal:  BMC Neurosci       Date:  2009-07-15       Impact factor: 3.288

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.